Tisi, Maria Chiara
 Distribuzione geografica
Continente #
NA - Nord America 1.802
EU - Europa 1.532
AS - Asia 1.108
SA - Sud America 159
AF - Africa 31
OC - Oceania 3
Totale 4.635
Nazione #
US - Stati Uniti d'America 1.767
DE - Germania 612
SG - Singapore 426
CN - Cina 348
SE - Svezia 164
PL - Polonia 163
IT - Italia 144
BR - Brasile 129
VN - Vietnam 121
FR - Francia 111
GB - Regno Unito 105
UA - Ucraina 72
IN - India 64
IE - Irlanda 39
FI - Finlandia 37
ID - Indonesia 28
TR - Turchia 26
RU - Federazione Russa 24
JP - Giappone 18
BD - Bangladesh 14
CA - Canada 14
BE - Belgio 13
MX - Messico 9
CI - Costa d'Avorio 8
HK - Hong Kong 8
IQ - Iraq 8
LT - Lituania 8
AT - Austria 7
NL - Olanda 7
PK - Pakistan 7
SA - Arabia Saudita 7
VE - Venezuela 7
ZA - Sudafrica 7
AR - Argentina 6
EC - Ecuador 6
ES - Italia 6
IR - Iran 6
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
EG - Egitto 4
PE - Perù 4
UZ - Uzbekistan 4
AL - Albania 3
IL - Israele 3
JM - Giamaica 3
MA - Marocco 3
PH - Filippine 3
RO - Romania 3
TN - Tunisia 3
CG - Congo 2
CL - Cile 2
DK - Danimarca 2
ET - Etiopia 2
JO - Giordania 2
MY - Malesia 2
NP - Nepal 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PW - Palau 1
SV - El Salvador 1
Totale 4.635
Città #
Singapore 252
Chandler 250
Ashburn 163
Warsaw 159
San Jose 119
Fairfield 80
Beijing 73
Jacksonville 67
Ann Arbor 65
New York 60
Nanjing 56
Nürnberg 48
Woodbridge 48
Dearborn 47
San Mateo 41
Dublin 39
Hanoi 39
Los Angeles 39
Munich 39
Wilmington 38
Houston 35
Seattle 35
Frankfurt am Main 33
Cattolica 30
Ho Chi Minh City 30
Jakarta 26
Lauterbourg 23
The Dalles 22
Chicago 21
Milan 21
Rome 21
Bremen 17
Helsinki 17
Lancaster 17
Nanchang 17
Hefei 16
Tokyo 16
Boston 15
Dallas 15
Kunming 15
Lawrence 14
London 14
Cambridge 13
Marseille 13
Moscow 13
Brussels 12
Redmond 12
Redwood City 11
Fremont 10
Princeton 10
São Paulo 10
Tianjin 10
Council Bluffs 9
Hyderabad 9
Jiaxing 9
Abidjan 8
Elk Grove Village 8
Guangzhou 8
Hangzhou 8
Hong Kong 8
Izmir 8
Salt Lake City 8
Santa Clara 8
Tampa 8
Atlanta 7
Boardman 7
Buffalo 7
Changsha 7
Norwalk 7
Brooklyn 6
Chengdu 6
Mumbai 6
Shanghai 6
Shenyang 6
Tukwila 6
Alghero 5
Amsterdam 5
Auburn Hills 5
Belo Horizonte 5
Da Nang 5
Düsseldorf 5
Haiphong 5
Hebei 5
Istanbul 5
Jinan 5
Johannesburg 5
Montreal 5
Poplar 5
University Park 5
Zhengzhou 5
Jeddah 4
Kocaeli 4
Las Vegas 4
Leawood 4
Mexico City 4
Orem 4
Phoenix 4
Romainville 4
Roubaix 4
Turku 4
Totale 2.591
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 432
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 343
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 329
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 294
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 282
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 235
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 222
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 181
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 172
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 159
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 158
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 156
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 156
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 155
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 154
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 151
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Small lymphocytic lymphoma in a patient with Fabry disease 141
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 131
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 121
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study 110
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 105
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 103
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report 101
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study 18
Totale 4.692
Categoria #
all - tutte 15.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.711


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022283 40 26 5 5 25 5 12 43 14 17 41 50
2022/2023604 72 83 45 120 28 84 28 51 73 5 9 6
2023/2024236 11 81 4 5 9 43 2 28 1 0 27 25
2024/2025479 16 24 46 26 52 11 27 12 57 43 94 71
2025/20261.298 184 34 103 113 248 88 246 56 91 85 32 18
Totale 4.692